Cánula nasal de alto flujo en pacientes críticos: una revisión narrativa
Barra lateral del artículo
Contenido principal del artículo
Resumen
La cánula nasal de alto flujo se ha convertido en una de las principales estrategias de soporte ventilatorio no invasivo en la insuficiencia respiratoria aguda hipoxémica, principalmente después de la pandemia de COVID-19. Sin embargo, su uso se extiende más allá de este escenario y abarca diferentes condiciones clínicas como el período postextubación, período postquirúrgico, insuficiencia respiratoria hipercápnica y soporte vital en pacientes inmunodeprimidos, trasplantados u oncológicos. Los manuscritos que avalan su aplicación han sido ampliamente difundidos y el grado de evidencia es lo suficientemente alto como para recomendar su uso. Por tanto, es necesario destacar sus efectos fisiológicos como el confort, una fracción inspirada de oxígeno precisa, el lavado de CO2 o la optimización del volumen pulmonar de fin de espiración para comprender su mecanismo de acción y mejorar los resultados de los pacientes.
El objetivo de esta revisión narrativa es ofrecer un resumen breve y conciso de los efectos y beneficios de aplicar esta terapia en diferentes escenarios clínicos sin la estructura rígida de una revisión sistemática. Con base en estas líneas, el lector curioso puede ampliar la evidencia científica que avala el empleo de la cánula nasal de alto flujo en cada escenario particular.
Descargas
Detalles del artículo
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Citas
Maggiore SM, Idone FA, Vaschetto R et al. Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome. Am J Respir Crit Care Med 2014; 190: 282-288. Doi: 10.1164/rccm.201402-0364OC.
Mauri T, Turrini C, Eronia N et al. Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure. Am J Respir Crit Care Med 2017; 195: 1207-1215. Doi: 10.1164/rccm.201605-0916OC.
Chanques G, Riboulet F, Molinari N et al. Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study. Minerva Anestesiol 2013; 79: 1344-1355.
Parke RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care 2013; 58: 1621-1624. Doi: 10.4187/respcare.02358.
Guérin C, Cour M, Degivry F, Argaud L, Louis B. A Bench Comparison of the Effect of High-Flow Oxygen Devices on Work of Breathing. Respir Care 2022 5:respcare.09889. Doi: 10.4187/respcare.09889.
Mauri T, Alban L, Turrini C et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med 2017; 43: 1453-1463. Doi: 10.1007/s00134-017-4890-1.
Dewan NA, Bell CW. Effect of low flow and high flow oxygen delivery on exercise tolerance and sensation of dyspnea. A study comparing the transtracheal catheter and nasal prongs. Chest 1994;105(4):1061-5. Doi: 10.1378/chest.105.4.1061.
Shepard JW Jr, Burger CD. Nasal and oral flow-volume loops in normal subjects and patients with obstructive sleep apnea. Am Rev Respir Dis 1990;142(6 Pt 1):1288-93. Doi: 10.1164/ajrccm/142.6_Pt_1.1288.
Moller W, Celik G, Feng S et al. Nasal high flow clears anatomical dead space in upper airway models. J Appl Physiol (1985) 2015; 118: 1525-1532.
Moller W, Feng S, Domanski U et al. Nasal high flow reduces dead space. J Appl Physiol (1985) 2017; 122: 191-197.
Vargas F, Saint-Leger M, Boyer A, Bui NH, Hilbert G. Physiologic Effects of High-Flow Nasal Cannula Oxygen in Critical Care Subjects. Respir Care 2015; 60: 1369-1376. Doi: 10.4187/respcare.03814.
Delorme M, Bouchard PA, Simon M, Simard S, Lellouche F. Effects of High-Flow Nasal Cannula on the Work of Breathing in Patients Recovering From Acute Respiratory Failure. Crit Care Med 2017; 45: 1981- 1988. Doi: 10.1097/CCM.0000000000002693.
Brochard L. Ventilation-induced lung injury exists in spontaneously breathing patients with acute respiratory failure: Yes. Intensive Care Med 2017; 43: 250-252. Doi: 10.1007/s00134-016-4645-4.
Hernandez G, Vaquero C, Gonzalez P et al. Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients: A Randomized Clinical Trial. JAMA 2016; 315: 1354-1361.
Tiruvoipati R, Lewis D, Haji K, Botha J. High-flow nasal oxygen vs high-flow face mask: a randomized crossover trial in extubated patients. J Crit Care 2010; 25: 463-468. Doi: 10.1016/j.jcrc.2009.06.050.
Rittayamai N, Tscheikuna J, Rujiwit P. High-flow nasal cannula versus conventional oxygen therapy after endotracheal extubation: a randomized crossover physiologic study. Respir Care 2014 Apr;59(4):485-90. Doi: 10.4187/respcare.02397.
Ricard JD, Roca O, Lemiale V et al. Use of nasal high fow oxygen during acute respiratory failure. Intensive Care Med 2020;46:2238–2247. Doi: 10.1007/s00134-020-06228-7.
Masclans JR, Pérez-Terána P, Roca O. The role of high flow oxygen therapy in acute respiratory failure. Doi: 10.1016/j.medin.2015.05.009.
Rochwerg B, Einav S, Chaudhuri D et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med 2020;46(12):2226-2237. Doi: 10.1007/s00134-020-06312-y.
Helviz Y, Einav S. A Systematic Review of the High-flow Nasal Cannula for Adult Patients. Critical Care 2018; 22:71. Doi: 10.1186/s13054-018-1990-4
Liang S, Liu Z, Qin Y, Wu Y. The effect of high flow nasal oxygen therapy in intensive care units: a systematic review and meta-analysis. Expert Rev Respir Med 2021; 15: 1335- 1345. Doi: 10.1080/17476348.2021.1937131.
Ou X, Hua Y, Liu J, Gong C, Zhao W. Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: a meta-analysis of randomized controlled trials. CMAJ 2017;189:E260-7. Doi: 10.1503/cmaj.160570.
Roca O, de Acilu MG, Caralt B et al. Humidified high flow nasal can- nula supportive therapy improves outcomes in lung transplant recipients readmitted to the intensive care unit because of acute respiratory failure. Transplantation 2015; 99:1092–1098
Frat JP, Thille AW, Mercat A et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015; 372(23):2185–2196. Doi: 10.1056/NEJMoa1503326.
Rochwerg B, Granton D, Wang DX et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 2019; 45:563–572. Doi: 10.1007/s00134-019-05590-5.
Doshi P, Whittle JS, Bublewicz M et al. High-velocity nasal insuflation in the treatment of respiratory failure: a randomized clinical trial. Ann Emerg Med 2018; 72:73–83.e5.
Ni YN, Luo J, Yu H et al. Can high-flow nasal cannula reduce the rate of endotracheal intubation in adult patients with acute respiratory failure compared with conventional oxygen therapy and noninvasive positive pressure ventilation? A systematic review and meta-analysis. Chest 2017; 151: 764- 775. Doi: 10.1016/j.chest.2017.01.004.
Monro-Somerville T, Sim M, Ruddy J et al. The effect of high-flow nasal cannula oxygen therapy on mortality and intubation rate in acute respiratory failure: a systematic review and meta-analysis. Crit Care Med 2017; 45:e449–e456. Doi: 10.1097/CCM.0000000000002091.
Mokart D, Geay C, Chow-Chine L et al. High-flow oxygen therapy in cancer patients with acute respiratory failure. Intensive Care Med 2015; 41: 2008-2010. Doi: 10.1007/s00134-015-3994-8.
Ansari BM, Hogan MP, Collier TJ et al. A Randomized Controlled Trial of High-Flow Nasal Oxygen (Optiflow) as Part of an Enhanced Recovery Program After Lung Resection Surgery. Ann Thorac Surg 2016; 101: 459-464. Doi: 10.1016/j.athoracsur.2015.07.025.
Futier E, Paugam-Burtz C, Godet T et al. Effect of early postextubation high-flow nasal cannula vs conventional oxygen therapy on hypoxaemia in patients after major abdominal surgery: a French multicentre randomised controlled trial (OPERA). Intensive Care Med 2016; 42: 1888- 1898. Doi: 10.1007/s00134-016-4594-y.
Ni YN, Luo J, Yu H et al. Can high-flow nasal cannula reduce the rate of reintubation in adult patients after extubation? A meta-analysis. BMC Pulm Med 2017; 17: 142.
Drake MG. High-Flow Nasal Cannula Oxygen in Adults: An Evidence-based Assessment. Ann Am Thorac Soc 2018; 15: 145-155.
Fernandez R, Subira C, Frutos-Vivar F et al. High-flow nasal cannula to prevent postextubation respiratory failure in high-risk non- hypercapnic patients: a randomized multicenter trial. Ann Intensive Care 2017; 7: 47. Doi: 10.1186/s13613-017-0270-9.
Chen L, Li HL, Brochard L. High-flow nasal cannula in postextubation management. J Thorac Dis 2016; 8: E1013-E1016.
Hu M, Zhou Q, Zheng R et al et al. Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study. BMC Pulm Med 2020;20(1):324. Doi: 10.1186/s12890-020-01354-w.
Delbove A, Foubert A, Mateos F, Guy T, Gousseff M. High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation? Ther Adv Respir Dis 2021;15:17534666211019555. Doi: 10.1177/17534666211019555.
Zhao Z, Cao H, Cheng Q, Li N, Zhang S, Ge Q. Effect of noninvasive positive pressure ventilation and high-flow nasal cannula oxygen therapy on the clinical efficacy of coronavirus disease 2019 patients with acute respiratory distress syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021;33(6):708-713. Doi: 10.3760/cma.j.cn121430-20210104-00002.
Colaianni-Alfonso N, Montiel G, Castro-Sayat M et al. Combined Noninvasive Respiratory Support Therapies to Treat COVID-19. Respir Care 2021;66(12):1831-1839. Doi: 10.4187/respcare.09162.
Ferrer S, Sancho J, Bocigas I, Bures E, Mora H, Monclou E. ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2. Respir Med 2021;189:106638. Doi: 10.1016/j.rmed.2021.106638.
Garner O, Dongarwar D, Salihu HM et al. Predictors of failure of high flow nasal cannula failure in acute hypoxemic respiratory failure due to COVID-19. Respir Med 2021;185:106474. Doi: 10.1016/j.rmed.2021.106474.
Duan J, Chen B, Liu X et al. Use of high-flow nasal cannula and noninvasive ventilation in patients with COVID-19: A multicenter observational study. Am J Emerg Med 2021;46:276-281. Doi: 10.1016/j.ajem.2020.07.071.
Teng XB, Shen Y, Han MF, Yang G, Zha L, Shi JF. The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia. Eur J Clin Invest 2021;51(3):e13435. Doi: 10.1111/eci.13435.
Ospina-Tascón GA, Calderón-Tapia LE, García AF et al. Effect of High-Flow vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Recovery in Severe COVID-19. JAMA 2021;326(21):2161-2171.
Perkins GD, Ji C, Connolly BA et al. An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19. 2021. MedRxiv (preprint) Doi: 10.1101/2021.08.02.21261379
Gallardo A, Dévoli AP, Arévalo GEB et al. High-Flow Nasal Cannula and Standard Oxygen in Acute Hypoxemic Respiratory Failure Due to COVID-19. Respir Care 2022; 19:respcare.10019. Doi: 10.4187/respcare.10019.
Crimi C, Noto A, Madotto F et al; COVID-HIGH Investigators. High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial. Thorax 2022:thoraxjnl-2022-218806. Doi: 10.1136/thoraxjnl-2022-218806.
Ehrmann S, Li J, Ibarra-Estrada M et al. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med 2021;9(12):1387-1395. Doi:10.1016/S2213-2600(21)00356-8
Perez-Nieto OR, Escarraman-Martinez D, Guerrero-Gutierrez MA et al. Awake prone positioning and oxygen therapy in patients with COVID-19: The APRONOX study [published online ahead of print, 2021 Jul 15]. Eur Respir J 2021;2100265. Doi:10.1183/13993003.00265-2021.
Esperatti M, Busico M, Fuentes N et al. Impact of exposure time in awake prone positioning on clinical outcomes of patients with COVID-19-related acute respiratory failure treated with high-flow nasal oxygen: a multicenter cohort study. Crit Care 2022;26(1):16. Doi: 10.1186/s13054-021-03881-2.
Pérez-Nieto OR, Guerrero-Gutiérrez MA, Deloya-Tomas E, Ñamendys-Silva SA. Prone positioning combined with high-flow nasal cannula in severe noninfectious ARDS. Crit Care 2020;24(1):114. Doi:10.1186/s13054-020-2821-y
Kaur R, Vines DL, Mirza S et al. Early versus late awake prone positioning in non-intubated patients with COVID-19. Crit Care 2021;25: 340. Doi: 10.1186/s13054-021-03761-9.
Bräunlich J, Goldner F, Wirtz H. Nasal highflow eliminates CO2 from lower airways. Respir Physiol Neurobiol 2017;242: 86-8.
Fricke K, Tatkov S, Domanski U, Franke KJ, Nilius G, Schneider H. Nasal high flow reduces hypercapnia by clearance of anatomical dead space in a COPD patient. Respir Med Case Rep 2016;19:115-117. Doi:10.1016/j.rmcr.2016.08.010.
Kim ES, Lee H, Kim SJ et al. Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. J Thorac Dis 2018;10(2):882-888. Doi:10.21037/jtd.2018.01.125
Alnajada A, Blackwood B, Mobrad A, Akhtar A, Shyamsundar M. High-flow nasal cannula therapy for initial oxygen administration in acute hypercapnic respiratory failure: study protocol of randomised controlled unblinded trial. BMJ Open Respir Res 2021;8(1):e000853. Doi:10.1136/bmjresp-2020-000853.
Su L, Zhao Q, Liu T, Xu Y, Li W, Zhang A. Efficacy of High-Flow Nasal Cannula Oxygen Therapy in Patients with Mild Hypercapnia. Lung 2021; 199: 447-456. Doi:10.1007/s00408-021-00472-4
Nam KH, Kang HK, Lee SS et al. Effects of high-flow nasal cannula in patients with mild to moderate hypercapnia: a prospective observational study. Acute and Critical Care 2021;36(3):249-255. Doi: 10.4266/acc.2020.01102.
Lee MK, Choi J, Park B et al. High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure. The Clinical Respiratory Journal 2018; 12(6): 2046–2056. Doi:10.1111/crj.12772.
McKinstry S, Pilcher J, Bardsley G et al. Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial. Respirology 2018;23(4):378-384. Doi: 10.1111/resp.13185.
Plotnikow GA, Accoce M, Fredes S et al. High-Flow Oxygen Therapy Application in Chronic Obstructive Pulmonary Disease Patients With Acute Hypercapnic Respiratory Failure: A Multicenter Study. Crit Care Explor 2021;3(2):e0337. Doi: 10.1097/CCE.0000000000000337.
Sun J, Li Y, Ling B et al. High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study. Int J Chron Obstruct Pulmon Dis 2019;14:1229-1237. Doi: 10.2147/COPD.S206567.
Kim ES, Lee H, Kim SJ et al. Effectiveness of high-flow nasal cannula oxygen therapy for acute respiratory failure with hypercapnia. Journal of Thoracic Disease 2018; 10(2): 882–888. Doi:10.21037/jtd.2018.01.125
Bae SH, Han M, Kim C et al. High-Flow Nasal Cannula Oxygen Therapy Can Be Effective for Patients in Acute Hypoxemic Respiratory Failure with Hypercapnia: a Retrospective, Propensity Score-Matched Cohort Study. J Korean Med Sci 2020;35(10):e67. Doi: 10.3346/jkms.2020.35.e67.
Ovtcharenko N, Ho E, Alhazzani W et al. High-flow nasal cannula versus non-invasive ventilation for acute hypercapnic respiratory failure in adults: a systematic review and meta-analysis of randomized trials. Crit Care 2022; 26: 348. Doi: 10.1186/s13054-022-04218-3.
Tan D, Walline JH, Ling B et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial. Crit Care 2020;24(1):489. Doi:10.1186/s13054-020-03214-9.
Lim BL, Ng WM, Lee WF. High flow nasal cannula oxygen versus noninvasive ventilation in adult acute respiratory failure: a systematic review of randomized-controlled trials. Eur J Emerg Med 2019;26(1):9-18. Doi: 10.1097/MEJ.0000000000000557.
Cortegiani A, Crimi C, Sanfilippo F et al. High flow nasal therapy in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. J Crit Care 2019;50:250-256. Doi: 10.1016/j.jcrc.2018.12.015.
Kang H, Zhao Z, Tong Z. Effect of high-flow nasal cannula oxygen therapy in immunocompromised subjects with acute respiratory failure. Respir Care 2020;65(3):369-376. Doi:10.4187/respcare.07205.
Zayed Y, Banifadel M, Barbarawi M et al. Noninvasive Oxygenation Strategies in Immunocompromised Patients With Acute Hypoxemic Respiratory Failure: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials. J Intensive Care Med 2020;35(11):1216-1225. Doi: 10.1177/0885066619844713.
Wang Y, Ni Y, Sun J, Liang Z. Use of High-Flow Nasal Cannula for Immunocompromise and Acute Respiratory Failure: A Systematic Review and Meta-Analysis. J Emerg Med 2020;58(3):413-423. Doi: 10.1016/j.jemermed.2020.01.016.
Cortegiani A, Crimi C, Sanfilippo F. High flow nasal therapy in immunocompromised patients with acute respiratory failure: A systematic review and meta-analysis. J Crit Care 2019;50:250-256. Doi: 10.1016/j.jcrc.2018.12.015.
Lemiale V, De Jong A, Dumas G et al; Groupe de Recherche en Reanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH). Oxygenation Strategy During Acute Respiratory Failure in Critically-Ill Immunocompromised Patients. Crit Care Med 2020;48(9):e768-e775. Doi: 10.1097/CCM.0000000000004456.
Coudroy R, Frat JP, Ehrmann S et al; REVA Network. High-flow nasal oxygen therapy alone or with non-invasive ventilation in immunocompromised patients admitted to ICU for acute hypoxemic respiratory failure: the randomised multicentre controlled FLORALI-IM protocol. BMJ Open 2019;9(8):e029798. Doi: 10.1136/bmjopen-2019-029798.
Lu Z, Chang W, Meng S et al. The Effect of High-Flow Nasal Oxygen Therapy on Postoperative Pulmonary Complications and Hospital Length of Stay in Postoperative Patients: A Systematic Review and Meta-Analysis. J Intensive Care Med 2020;35(10):1129-1140. Doi: 10.1177/0885066618817718.
Chaudhuri D, Granton D, Wang DX et al. High-Flow Nasal Cannula in the Immediate Postoperative Period. Chest 2020;158(5):1934–1946. Doi:10.1016/j.chest.2020.06.038.
Xiang G, Wu Q, Xie L et al. High flow nasal cannula versus conventional oxygen therapy in postoperative patients at high risk for pulmonary complications: a systematic review and meta‐analysis. Int J Clin Pract 2021; 75: 613828. Doi:10.1111/ijcp.13828.
Xia M, Li W,Yao J et al. A postoperative comparison of high-flow nasal cannula therapy and conventional oxygen therapy for esophageal cancer patients. Ann Palliat Med 2021;10(3):2530-2539. Doi: 10.21037/apm-20-1539.
Sakles JC, Mosier JM, Patanwala AE, Dicken JM. Apneic oxygenation is associated with a reduction in the incidence of hypoxemia during the RSI of patients with intracranial hemorrhage in the emergency department. Intern Emerg Med 2016;11(7):983-92. Doi: 10.1007/s11739-016-1396-8.
Sakles JC, Mosier JM, Patanwala AE, Arcaris B, Dicken JM. First Pass Success Without Hypoxemia Is Increased With the Use of Apneic Oxygenation During Rapid Sequence Intubation in the Emergency Department. Acad Emerg Med 2016;23(6):703-10. Doi: 10.1111/acem.12931.
Semler MW, Janz DR, Lentz RJ et al; FELLOW Investigators; Pragmatic Critical Care Research Group. Randomized Trial of Apneic Oxygenation during Endotracheal Intubation of the Critically Ill. Am J Respir Crit Care Med 2016;193(3):273-80. Doi: 10.1164/rccm.201507-1294OC.
Jaber S, Monnin M, Girard M et al. Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial. Intensive Care Med 2016;42(12):1877-1887. Doi: 10.1007/s00134-016-4588-9.
Lodenius Å, Piehl J, Östlund A, Ullman J, Jonsson Fagerlund M. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) vs. facemask breathing pre-oxygenation for rapid sequence induction in adults: a prospective randomised non-blinded clinical trial. Anaesthesia 2018;73(5):564-571. Doi: 10.1111/anae.14215.
Ng I, Krieser R, Mezzavia P et al. The use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for pre-oxygenation in neurosurgical patients: a randomised controlled trial. Anaesth Intensive Care 2018 ;46(4):360-367. Doi: 10.1177/0310057X1804600403.
Heinrich S, Horbach T, Stubner B, Prottengeier J, Irouschek A, Schmidt J. Benefits if heated and humidified high flow nasal oxygen for preoxygenation in morbidly obese patients undergoing bariatric surgery: a randomized controlled study. J Obes Bariatrics 2014;1(1):7.
Tan PCF, Millay OJ, Leeton L, Dennis AT. High-flow humidified nasal preoxygenation in pregnant women: a prospective observational study. Br J Anaesth 2019;122(1):86-91. Doi: 10.1016/j.bja.2018.08.015.
Gallardo A, Gigliotti C, Saavedra S, Zamarrón-López EI, Guerrero-Gutiérrez MA, Pérez-Nieto OR. Strategies for monitoring and predicting failure to high-flow nasal cannula therapy in the ED. American Journal of Emergency Medicine 2022; 57: 183-184. Doi: 10.1016/j.ajem.2021.12.046.
Roca O, Messika J, Caralt B et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care 2016;35:200-5. Doi: 10.1016/j.jcrc.2016.05.022.
Roca O, Caralt B, Messika J et al. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med 2019;199(11):1368-1376. Doi: 10.1164/rccm.201803-0589OC.
Karim HMR, Esquinas AM. Success or failure of high flow nasal oxygen therapy: ROX index is good, modified ROX may be better. Am J Respir Crit Care Med 2019;200(1):116-117.
Goh KJ, Chai HZ, Ong TH et al. Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate. J Intensive Care 2020;8:41. Doi: 10.1186/s40560-020-00458-z.
Valencia CF, Lucero OD, Castro OC et al. Comparison of ROX and HACOR scales to predict high-flow nasal cannula failure in patients with SARS-CoV-2 pneumonia. Sci Rep 2021;11:22559. Doi: 10.1038/s41598-021-02078-5
Blez D, Soulier A, Bonnet F, Gayat E, Garnier M. Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate. Intensive Care Med 2020;46(11):2094–5. Doi: 10.1007/s00134-020-06199-9.
Apigo M, Schechtman J, Dhliwayo N et al. Development of a work of breathing scale and monitoring need of intubation in COVID-19 pneumonia. Crit Care 2020; 24: 477. Doi: 10.1186/s13054-020-03176-y
Gallardo A, Zamarrón-López E, Deloya-Tomas E, Pérez-Nieto OR. Advantages and limitations of the ROX index [published online ahead of print, 2022 Mar 23]. Pulmonology 2022;S2531-0437(22)00071-X. Doi:10.1016/j.pulmoe.2022.02.008
González J, Benítez ID, de Gonzalo-Calvo D et al. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study. Crit Care 2022;26:18. Doi: 10.1186/s13054-021-03882-1.
Rello J, Pérez M, Roca O et al. High-flow nasal therapy in adults with severe acute respiratory infection: a cohort study in patients with 2009 influenza A/H1N1v. J Crit Care 2012;27:434–439. Doi: 10.1016/j.jcrc.2012.04.006.
Kang BJ, Koh Y, Lim C-M et al. Failure of high-fow nasal cannula therapy may delay intubation and increase mortality. Intensive Care Med 2015;41:623–632. Doi: 10.1007/s00134-015-3693-5.